Reason for withdrawal from publication
This review has been withdrawn as it was published over two years ago and an updated review has not yet been submitted.This review is being withdrawn and a new protocol wirtten, major changes in methods have mandated this.
The editorial group responsible for this previously published document have withdrawn it from publication.
Keywords: Female; Humans; Danazol; Danazol/therapeutic use; Endometriosis; Endometriosis/complications; Fertility Agents, Female; Fertility Agents, Female/therapeutic use; Gestrinone; Gestrinone/therapeutic use; Gonadotropin‐Releasing Hormone; Gonadotropin‐Releasing Hormone/analogs & derivatives; Gonadotropin‐Releasing Hormone/therapeutic use; Pain; Pain/drug therapy; Pain/etiology
What's new
| Date | Event | Description |
|---|---|---|
| 17 March 2010 | Review declared as stable | This review is being withdrawn and a new protocol wirtten, major changes in methods have mandated this. |
History
Protocol first published: Issue 1, 1997 Review first published: Issue 1, 1998
| Date | Event | Description |
|---|---|---|
| 23 June 2008 | Amended | Converted to new review format. |
| 1 January 1999 | New citation required and conclusions have changed | Substantive amendment |
Sources of support
Internal sources
University of Cambridge, UK.
University of Auckland, New Zealand.
External sources
BMJ Publishing, UK.
Zeneca Pharma, UK.
Withdrawn from publication for reasons stated in the review